.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M02A_TopicalProductsForJointAndMuscularPain.M02AA17_NiflumicAcid.NiflumicAcid .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M02A_TopicalProductsForJointAndMuscularPain.M02AA17_NiflumicAcid.NiflumicAcid| name: | NiflumicAcid | |
| ATC code: | M02AA17 | route: | oral |
| compartments: | 1 | |
| dosage: | 250 | mg |
| volume of distribution: | 10 | L |
| clearance: | 0.5 | L/h |
| other parameters in model implementation | ||
Niflumic acid is a non-steroidal anti-inflammatory drug (NSAID) of the anthranilic acid derivative class. It is used mainly for its analgesic and anti-inflammatory actions in the management of musculoskeletal pain and inflammation, particularly in rheumatology. Its clinical use has declined and is largely limited to certain regions; it is not widely approved or marketed today.
Estimated pharmacokinetic parameters for a typical healthy adult after oral administration, as no published compartmental PK models or population PK data are readily available for niflumic acid.